LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026GlobeNewsWire · Oct 12, 2026
LeMaitre Vascular: The Q2 Miss Hides A Stronger Acquisition MachineSeeking Alpha · Oct 1, 2026
LeMaitre Vascular Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Customer Data Is ExposedPRNewsWire · Sep 23, 2026
PAHC or LMAT: Which Is the Better Value Stock Right Now?Zacks Investment Research · Sep 2, 2026
LeMaitre to Participate at Upcoming Investor Conferences in SeptemberGlobeNewsWire · Aug 27, 2026
Dividend Champion, Contender, And Challenger Highlights: Week August 16Seeking Alpha · Aug 14, 2026Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 4, 2026 | $0.81 | $0.74 | Miss |
| May 5, 2026 | $0.66 | $0.68 | Beat |
| Feb 25, 2026 | $0.67 | $0.68 | Beat |
| Nov 6, 2025 | $0.56 | $0.62 | Beat |
| Aug 5, 2025 | $0.57 | $0.60 | Beat |
| May 1, 2025 | $0.50 | $0.48 | Miss |